News

£105 million DES cash freed but correction factors cut

23-Jul-08

Correction factor cuts proposed by the Doctors' and Dentists' Review Body (DDRB) this year are almost certain to go ahead, the GPC has admitted.

GP leaders said they had successfully argued the cuts were illegal, but the DoH had begun a 12-week consultation to enable it to force the change through.

The move means that the 2.7 per cent global sum uplift proposed by the DDRB will be absorbed by an equivalent cut to correction factors for the 90 per cent of practices that rely on the pay top-up.

However, the move will break the deadlock between negotiators, and means GPs in England will finally see the £105 million set aside for directed enhanced services (DESs).

The five clinical DESs and the extended hours DESs funded by the cash will be ready 'very soon', said GPC chairman Dr Laurence Buckman.

GPC negotiators say the DoH acknowledged that the DDRB recommendation to cut correction factors was illegal, so it is now consulting on how to implement it legally.

GPC deputy chairman Dr Richard Vautrey said: 'We will challenge this in our response, which is in the hands of our lawyers.'

But he expected the government to change the contract's statement of financial entitlement to allow the cuts.

tom.ireland@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

nMRCGP - Make sure you can ace the AKT

Dr Chris Elfes gives a trainer's perspective on how to pass the applied knowledge test. Read more

nMRCGP exam update - Evidence for aspirin use

Contributed by Dr Louise Newson, a GP in the West Midlands. Read more

RCGP curriculum - Introducing the GP curriculum

Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more

Show all articles

 

Latest Clinical Articles

Clincal Review: Gout

Contributed by Dr Richard Stevens, consultant rheumatologist, Buckinghamshire Hospitals. Read more

Altitude-related illness

Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more

Clinical Review - Subfertility in women

Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more

Show all clinical articles

MIMS Product News

Relistor

New drug - Relistor

Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more

Thalidomide available in the UK

Thalidomide, under the name of Thalidomide Pharmion is now commercially available in the UK. Read more

MMR catch-up programme

The DoH has written to healthcare professionals to call for urgent action to help reduce the risk of... Read more

Jobs

 

Job of the Week